Effect of recombinant human granulocyte-macrophage colony stimulating factor on wound healing in patients with deep partial thickness burn / 中华烧伤杂志
Chinese Journal of Burns
;
(6): 107-110, 2008.
Article
in Chinese
| WPRIM
| ID: wpr-347630
ABSTRACT
<p><b>OBJECTIVE</b>To evaluate the efficacy and safety of recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) hydrogel in wound healing in patients with deep partial thickness burn.</p><p><b>METHODS</b>The study was a multicenter, randomized, double-blind, placebo-controlled parallel clinical trial. Three hundred and twenty-one patients (302 cases finally fulfilled the protocol) with deep partial thickness burn were divided into A group (n = 200, with treatment of rhGM-CSF hydrogel, 100 microg/10 g/100 cm2/d), C group (n = 102,with treatment of placebo). Side-effect, systemic condition, wound healing time, wound healing rate, and total effective rate at different time points were observed.</p><p><b>RESULTS</b>There were no obvious differences in vital signs, wound secretion, wound edge reaction, blood and urine routine, liver and kidney function between two groups (P > 0.05). No side-effect was observed. The median wound healing time was 17 days in A group, which was obviously shorter than that in C group (20 days, P < 0.01). The mean wound healing rate in A group was 24.5%, 70.5%, 95.3%, 99.6% respectively on 8th, 14th, 20th, 28th day after treatment, which were obviously higher than that in C group (15.1%, 51.4%, 84.6%, 97.1%, respectively, P < 0.01). The total effective rates in A group on 8th, 14th, 20th day after treatment were also higher than that in C group (P < 0.01).</p><p><b>CONCLUSION</b>rhGM-CSF hydrogel can significantly accelerate wound healing in patients with deep partial thickness burn with certain safety.</p>
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Placebos
/
Wound Healing
/
Recombinant Proteins
/
Burns
/
Double-Blind Method
/
Granulocyte-Macrophage Colony-Stimulating Factor
/
Hydrogels
/
Therapeutic Uses
/
Drug Therapy
Type of study:
Controlled clinical trial
/
Practice guideline
Limits:
Female
/
Humans
/
Male
Language:
Chinese
Journal:
Chinese Journal of Burns
Year:
2008
Type:
Article
Similar
MEDLINE
...
LILACS
LIS